Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.994
-0.038 (-1.25%)
Jun 5, 2026, 5:36 PM CET
Oryzon Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.06 | -3.7 | -3.71 | -4.52 | -5.33 |
Depreciation & Amortization | 0.14 | 0.13 | 0.14 | 0.16 | 0.15 |
Other Amortization | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 |
Asset Writedown & Restructuring Costs | 0 | - | - | - | 0 |
Other Operating Activities | -0.45 | -1.24 | 3.74 | 1.03 | -1.39 |
Change in Accounts Receivable | -0.35 | 0.01 | 0.37 | 0.31 | -0.12 |
Change in Inventory | -0 | 0 | 0 | 0.1 | 0.24 |
Change in Accounts Payable | 1.18 | -0.95 | -1.25 | 0.93 | 1.38 |
Change in Other Net Operating Assets | -0.25 | -0.16 | 0.03 | 0 | 0.93 |
Operating Cash Flow | -2.77 | -5.89 | -0.64 | -1.97 | -4.12 |
Capital Expenditures | -0.07 | -0.11 | - | -0.08 | -0.2 |
Sale (Purchase) of Intangibles | -12.89 | -7.98 | -16.03 | -15.17 | -13.18 |
Other Investing Activities | 0 | - | -0 | -0 | 0.04 |
Investing Cash Flow | -12.96 | -8.09 | -16.03 | -15.25 | -13.33 |
Short-Term Debt Issued | - | 7.25 | 15.22 | 9.57 | - |
Long-Term Debt Issued | 17.01 | 6.76 | 1.93 | 5.47 | 9.05 |
Total Debt Issued | 17.01 | 14.01 | 17.15 | 15.04 | 9.05 |
Short-Term Debt Repaid | -5.51 | - | -0.9 | - | - |
Long-Term Debt Repaid | -7.84 | -8.44 | -7.52 | -4.73 | -4.36 |
Total Debt Repaid | -13.35 | -8.44 | -8.42 | -4.73 | -4.36 |
Net Debt Issued (Repaid) | 3.67 | 5.56 | 8.73 | 10.3 | 4.69 |
Issuance of Common Stock | 33.64 | 0.07 | - | - | - |
Repurchase of Common Stock | - | - | -1.99 | -1.07 | - |
Other Financing Activities | 5.12 | 1.48 | -0.09 | 0.07 | - |
Financing Cash Flow | 42.42 | 7.11 | 6.66 | 9.31 | 4.69 |
Foreign Exchange Rate Adjustments | -0.01 | -0.01 | -0 | 0 | 0.4 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - |
Net Cash Flow | 26.69 | -6.87 | -10.01 | -7.92 | -12.37 |
Free Cash Flow | -2.84 | -6 | -0.64 | -2.06 | -4.32 |
Free Cash Flow Margin | -22.09% | -78.70% | -4.05% | -12.25% | -35.82% |
Free Cash Flow Per Share | -0.04 | -0.09 | -0.01 | -0.04 | -0.08 |
Cash Interest Paid | 0.39 | 0.39 | 0.44 | 0.34 | 0.29 |
Cash Income Tax Paid | -2.05 | - | -5.16 | -2.65 | -1.48 |
Levered Free Cash Flow | -13.93 | -13.54 | -20.58 | -17.29 | -17.89 |
Unlevered Free Cash Flow | -13.93 | -13.54 | -19.27 | -16.54 | -17.56 |
Change in Working Capital | 0.58 | -1.1 | -0.84 | 1.34 | 2.43 |